These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results Terminated 2016-003287-39 A Phase II Open-Label Study of NUC-1031 in Patients with Platinum-Resistant Ovarian Cancer 2019-12-31 due-trials
Listed as ongoing, but also has a completion date and reported results 2019-001025-28 A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Trac... 2022-03-02 bad-data
Ongoing 2022-001459-17 A randomised, open-label, Phase II, dose/schedule optimisation study of NUC-3373/leucovorin/irinotecan plus bevacizumab (NUFIRI-bev) versus 5-FU/leucovorin/irinotecan plus bevacizumab (FOLFIRI-bev) fo... not-yet-due